Avience Biomedicals Ltd vs Invicta Diagnostic Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Avience Biomedicals Ltd is ₹ 240 as of 23 Oct 15:30 . The P/E Ratio of Avience Biomedicals Ltd is 0 as of March 2024 .The P/E Ratio of Invicta Diagnostic Ltd is 0 as of March 2024 . The Market Cap of Avience Biomedicals Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Invicta Diagnostic Ltd is ₹ 0 crore as of March 2024 . The Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2024 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Invicta Diagnostic Ltd changed from 0 % on March 2024 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years .

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

About Invicta Diagnostic Ltd

Invicta Diagnostic Limited was incorporated as Limited Liability Partnership under the name 'Invicta Diagnostic LLP' vide Certificate of Incorporation dated January 22, 2021 issued by Assistant Registrar of Companies, Central Registration Centre.
Further, Invicta Diagnostic LLP converted into a Private Limited Company as 'Invicta Diagnostic Private Limited' dated December 01, 2023.
Subsequently, Company converted from a Private Limited to a Public Limited Company, and the name was changed to 'Invicta Diagnostic Limited' and a fresh Certificate of Incorporation dated July 02, 2024 was issued by the Central Processing Centre. Invicta Diagnostic Limited is an innovative diagnostic chain in Mumbai Metropolitan Region (MMR) offering comprehensive radiology and pathology solutions.
It offer a one-stop solution for pathology and radiology testing services such as imaging (including radiology) and pathology/clinical laboratory to customers through a network, consisting of 8 diagnostic centres and 1 centralised laboratory across Mumbai Metropolitan Region in Maharashtra.

FAQs for the comparison of Avience Biomedicals Ltd and Invicta Diagnostic Ltd

Which company has a larger market capitalization, Avience Biomedicals Ltd or Invicta Diagnostic Ltd?

Market cap of Avience Biomedicals Ltd is 131 Cr while Market cap of Invicta Diagnostic Ltd is 76 Cr

What are the key factors driving the stock performance of Avience Biomedicals Ltd and Invicta Diagnostic Ltd?

The stock performance of Avience Biomedicals Ltd and Invicta Diagnostic Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Avience Biomedicals Ltd and Invicta Diagnostic Ltd?

As of October 25, 2026, the Avience Biomedicals Ltd stock price is INR ₹240.0. On the other hand, Invicta Diagnostic Ltd stock price is INR ₹60.5.

How do dividend payouts of Avience Biomedicals Ltd and Invicta Diagnostic Ltd compare?

To compare the dividend payouts of Avience Biomedicals Ltd and Invicta Diagnostic Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.